At a PhRMA forum, CMS Administrator Mehmet Oz had a cordial exchange advocating for vaccine benefits and government-industry collaboration, while FDA Commissioner Marty Makary faced tough questions about stricter vaccine regulations. This highlights a divide within the health secretary's team regarding industry engagement and regulatory approach, signaling mixed messages that could affect content creators covering healthcare policy and pharmaceutical industry relations.
Read the full article at STAT Pharma
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



